Trials / Completed
CompletedNCT00901004
The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire
Non-interventional, Cross-sectional, Multi-center Study to Establish The Clinical Significance of Minimal Change in Reflux Esophagitis Based on the Gastroesophageal Reflux Disease Questionnaire (GerdQ)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,550 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to define the endoscopic findings of minimal change that is significant to clinical significant reflux esophagitis. Through this, the investigators want to estimate the applicability of minimal change findings of reflux esophagitis to the clinic.
Conditions
Timeline
- Start date
- 2009-04-01
- Completion
- 2009-09-01
- First posted
- 2009-05-13
- Last updated
- 2010-12-07
Locations
7 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00901004. Inclusion in this directory is not an endorsement.